Outcome Markers for Clinical Trials in Cerebral Amyloid Angiopathy

Efforts are underway for early-phase trials of candidate therapies for cerebral amyloid angiopathy (CAA), an untreatable cause of hemorrhagic stroke and vascular cognitive impairment. A major barrier to these trials is the lack of consensus on measuring treatment effectiveness. We review a range of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Greenberg, Steven M., Rustam Al-Shahi, Salman, Biessels, Geert Jan, van Buchem, Mark, Cordonnier, Charlotte, Lee, Jin-Moo, Montaner, Joan, Schneider, Julie A., Smith, Eric E, Vernooij, Meike, Werring, David J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4085787/
https://ncbi.nlm.nih.gov/pubmed/24581702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(14)70003-1
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge